Development of Clinical Trials to Extend Healthy Lifespan

Overview

Journal Cardiovasc Endocrinol Metab

Specialty Cardiology & Vascular Diseases

Date 2019 Mar 26

PMID 30906924

Citations 44

Authors

Jamie N Justice

Laura Niedernhofer

Paul D Robbins

Vanita R Aroda

Mark A Espeland

Stephen B Kritchevsky

George A Kuchel

Nir Barzilai

Affiliations

Soon will be listed here.

Abstract

Significant progress in defining the biology of aging, particularly in animal models, supports the geroscience hypothesis, which posits that by therapeutically targeting biological aging, the onset of multiple age-related diseases can be delayed "en suite". Geroscience investigators are preparing to test this hypothesis in humans for the first time. In this review, we describe development of large-scale clinical trials designed to determine if multiple age-related health conditions can be simultaneously alleviated with interventions targeting the underlying biology of aging. We describe the rationale and collaborative, consensus building approach used to design the first aging outcomes trial called Targeting Aging with Metformin (TAME). Through this case study, we outline features that could be more broadly extended to other geroscience-guided clinical trials, including a process for selecting biochemical and molecular markers of biologic age and we provide a perspective on the potential impact of clinical trials targeting aging.

Citing Articles

Roadmap for alleviating the manifestations of ageing in the cardiovascular system.

Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M Nat Rev Cardiol. 2025; .

PMID: 39972009 DOI: 10.1038/s41569-025-01130-5.

Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanisms.

Stubbs B, Alvarez Azanedo G, Peralta S, Diaz S, Gray W, Alexander L PLoS One. 2024; 19(9):e0307951.

PMID: 39292659 PMC: 11410252. DOI: 10.1371/journal.pone.0307951.

Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.

Seo D, Corr M, Patel S, Lui L, Cauley J, Evans D Osteoporos Int. 2024; 35(10):1789-1796.

PMID: 38965121 PMC: 11427528. DOI: 10.1007/s00198-024-07160-y.

Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults.

Kuo C, Chen Z, Liu P, Pilling L, Atkins J, Fortinsky R Aging Cell. 2024; 23(8):e14195.

PMID: 38747160 PMC: 11320350. DOI: 10.1111/acel.14195.

Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults.

Kuo C, Chen Z, Liu P, Pilling L, Atkins J, Fortinsky R medRxiv. 2024; .

PMID: 38196645 PMC: 10775323. DOI: 10.1101/2023.12.19.23300228.

References

Harrison D, Strong R, Allison D, Ames B, Astle C, Atamna H . Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2013; 13(2):273-82. PMC: 3954939. DOI: 10.1111/acel.12170. View

Bartke A, Wright J, Mattison J, Ingram D, Miller R, Roth G . Extending the lifespan of long-lived mice. Nature. 2001; 414(6862):412. DOI: 10.1038/35106646. View

Longo V, Antebi A, Bartke A, Barzilai N, Brown-Borg H, Caruso C . Interventions to Slow Aging in Humans: Are We Ready?. Aging Cell. 2015; 14(4):497-510. PMC: 4531065. DOI: 10.1111/acel.12338. View

Xu M, Pirtskhalava T, Farr J, Weigand B, Palmer A, Weivoda M . Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018; 24(8):1246-1256. PMC: 6082705. DOI: 10.1038/s41591-018-0092-9. View

Espeland M, Crimmins E, Grossardt B, Crandall J, Gelfond J, Harris T . Clinical Trials Targeting Aging and Age-Related Multimorbidity. J Gerontol A Biol Sci Med Sci. 2017; 72(3):355-361. PMC: 5777384. DOI: 10.1093/gerona/glw220. View

Allard J, Perez E, Fukui K, Carpenter P, Ingram D, de Cabo R . Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice. Behav Brain Res. 2015; 301:1-9. PMC: 4823003. DOI: 10.1016/j.bbr.2015.12.012. View

Khan S, Singer B, Vaughan D . Molecular and physiological manifestations and measurement of aging in humans. Aging Cell. 2017; 16(4):624-633. PMC: 5506433. DOI: 10.1111/acel.12601. View

Newman J, Milman S, Hashmi S, Austad S, Kirkland J, Halter J . Strategies and Challenges in Clinical Trials Targeting Human Aging. J Gerontol A Biol Sci Med Sci. 2016; 71(11):1424-1434. PMC: 5055653. DOI: 10.1093/gerona/glw149. View

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

10.

Niedernhofer L, Robbins P . Senotherapeutics for healthy ageing. Nat Rev Drug Discov. 2018; 17(5):377. DOI: 10.1038/nrd.2018.44. View

11.

Barzilai N, Crandall J, Kritchevsky S, Espeland M . Metformin as a Tool to Target Aging. Cell Metab. 2016; 23(6):1060-1065. PMC: 5943638. DOI: 10.1016/j.cmet.2016.05.011. View

12.

. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015; 3(11):866-75. PMC: 4623946. DOI: 10.1016/S2213-8587(15)00291-0. View

13.

Belsky D, Caspi A, Houts R, Cohen H, Corcoran D, Danese A . Quantification of biological aging in young adults. Proc Natl Acad Sci U S A. 2015; 112(30):E4104-10. PMC: 4522793. DOI: 10.1073/pnas.1506264112. View

14.

Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View

15.

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

16.

Martin-Montalvo A, Mercken E, Mitchell S, Palacios H, Mote P, Scheibye-Knudsen M . Metformin improves healthspan and lifespan in mice. Nat Commun. 2013; 4:2192. PMC: 3736576. DOI: 10.1038/ncomms3192. View

17.

Harrison D, Strong R, Sharp Z, Nelson J, Astle C, Flurkey K . Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392-5. PMC: 2786175. DOI: 10.1038/nature08221. View

18.

. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1603-1658. PMC: 5388857. DOI: 10.1016/S0140-6736(16)31460-X. View

19.

Kennedy B, Berger S, Brunet A, Campisi J, Cuervo A, Epel E . Geroscience: linking aging to chronic disease. Cell. 2014; 159(4):709-13. PMC: 4852871. DOI: 10.1016/j.cell.2014.10.039. View

20.

Nadon N, Strong R, Miller R, Nelson J, Javors M, Sharp Z . Design of aging intervention studies: the NIA interventions testing program. Age (Dordr). 2009; 30(4):187-99. PMC: 2585647. DOI: 10.1007/s11357-008-9048-1. View